AmSurg receives average “buy” rating

Eleven analyst firms have given AmSurg stock an average rating of “buy,” according to a report from The Legacy.

Advertisement
Carrie Pallardy

AmSurg stock has an average 12-month price target of $67.45. The company’s stock has a 50-day moving average of $65 and a 200-day moving average of $58, according to the report.

More articles on transactions and valuation issues:
4 recent orthopedics-driven ASC plans & openings
Ellis Hospital is crowdfunding its new surgery center: 4 insights
Nobilis Healthcare receives $25M loan from GE Capital

How AdventHealth unlocked $24M in 4 months

Recommended Whitepaper

Advertisement

Next Up in ASC Transactions & Valuation Issues

  • Was 2025 physicians' toughest year yet?

    Eight physicians joined Becker’s to discuss the challenges that hit hardest this year, including staffing shortages, administrative burdens, payer dysfunction…

    By: Patsy Newitt

  • The ASC-hospital wage war intensifies

    ASCs are facing mounting workforce strain as hospitals continue to outpay them for nurses and surgical staff, a gap that…

    By: Patsy Newitt
Advertisement

Comments are closed.